212 related articles for article (PubMed ID: 25978433)
1. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells.
Lai YS; Chen JY; Tsai HJ; Chen TY; Hung WC
Blood Cancer J; 2015 May; 5(5):e313. PubMed ID: 25978433
[TBL] [Abstract][Full Text] [Related]
2. Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1.
Chaib H; Nebbioso A; Prebet T; Castellano R; Garbit S; Restouin A; Vey N; Altucci L; Collette Y
Leukemia; 2012 Apr; 26(4):662-74. PubMed ID: 21979880
[TBL] [Abstract][Full Text] [Related]
3. Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.
Tran HT; Kim HN; Lee IK; Nguyen-Pham TN; Ahn JS; Kim YK; Lee JJ; Park KS; Kook H; Kim HJ
J Korean Med Sci; 2013 Feb; 28(2):237-46. PubMed ID: 23400519
[TBL] [Abstract][Full Text] [Related]
4. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response.
Bernhard W; Barreto K; Saunders A; Dahabieh MS; Johnson P; Sadowski I
FEBS Lett; 2011 Nov; 585(22):3549-54. PubMed ID: 22020221
[TBL] [Abstract][Full Text] [Related]
5. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.
Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR
Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540
[TBL] [Abstract][Full Text] [Related]
6. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
[TBL] [Abstract][Full Text] [Related]
7. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
8. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201.
Xin DE; Liao Y; Rao R; Ogurek S; Sengupta S; Xin M; Bayat AE; Seibel WL; Graham RT; Koschmann C; Lu QR
Neuro Oncol; 2024 Apr; 26(4):735-748. PubMed ID: 38011799
[TBL] [Abstract][Full Text] [Related]
9. 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.
Füller M; Klein M; Schmidt E; Rohde C; Göllner S; Schulze I; Qianli J; Berdel WE; Edemir B; Müller-Tidow C; Tschanter P
Int J Oncol; 2015 Mar; 46(3):1192-204. PubMed ID: 25501798
[TBL] [Abstract][Full Text] [Related]
10. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
11. Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells.
Liu X; Guo S; Liu X; Su L
Apoptosis; 2015 Nov; 20(11):1499-507. PubMed ID: 26349783
[TBL] [Abstract][Full Text] [Related]
12. Effects of histone methyltransferase inhibitor chaetocin on histone H3K9 methylation of cultured ovine somatic cells and development of preimplantation cloned embryos.
Zhang YM; Gao EE; Wang QQ; Tian H; Hou J
Reprod Toxicol; 2018 Aug; 79():124-131. PubMed ID: 29909068
[TBL] [Abstract][Full Text] [Related]
13. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.
Bouchat S; Gatot JS; Kabeya K; Cardona C; Colin L; Herbein G; De Wit S; Clumeck N; Lambotte O; Rouzioux C; Rohr O; Van Lint C
AIDS; 2012 Jul; 26(12):1473-82. PubMed ID: 22555163
[TBL] [Abstract][Full Text] [Related]
14. Chaetocin disrupts the SUV39H1-HP1 interaction independent of SUV39H1 methyltransferase activity.
Han L; Lee JB; Indermaur EW; Keung AJ
Biochem J; 2023 Mar; 480(6):421-432. PubMed ID: 36896918
[TBL] [Abstract][Full Text] [Related]
15. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
Gozzini A; Santini V
Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
[TBL] [Abstract][Full Text] [Related]
16. High Glucose Increases the Expression of Inflammatory Cytokine Genes in Macrophages Through H3K9 Methyltransferase Mechanism.
Li MF; Zhang R; Li TT; Chen MY; Li LX; Lu JX; Jia WP
J Interferon Cytokine Res; 2016 Jan; 36(1):48-61. PubMed ID: 26406561
[TBL] [Abstract][Full Text] [Related]
17. SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90.
Lian B; Lin Q; Tang W; Qi X; Li J
Biomol Ther (Seoul); 2021 Jan; 29(1):73-82. PubMed ID: 33162400
[TBL] [Abstract][Full Text] [Related]
18. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
Spensberger D; Delwel R
FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia.
Gopalakrishnapillai A; Kolb EA; McCahan SM; Barwe SP
Leuk Res; 2017 Jul; 58():91-97. PubMed ID: 28505595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
